Contact this trialFirst, we need to learn more about you.
Vasodilator
Inhaled Nitric Oxide for Pulmonary Conditions in Preterm Infants
Recruiting0 awardsPhase 1 & 2
Orlando, Florida
This trial is testing whether inhaled nitric oxide can decrease the incidence of death and bronchopulmonary dysplasia, and improve oxygenation, in extremely preterm infants.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.